Research Progress in Pharmaceutical Crystallization

A special issue of Crystals (ISSN 2073-4352). This special issue belongs to the section "Industrial Crystallization".

Deadline for manuscript submissions: 31 October 2026 | Viewed by 141

Special Issue Editors


E-Mail Website
Guest Editor
School of Pharmaceutical Sciences (Shandong Analysis and Test Center), Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, China
Interests: pharmaceutical crystallization; polymorphism; physical pharmaceutics; morphological regulation; dissolution thermodynamics
School of Pharmaceutical Sciences (Shandong Analysis and Test Center), Qilu University of Technology (Shandong Academy of Sciences), Jinan, China
Interests: industrial crystallization; pharmaceutical crystallization; crystal engineering; crystal process design and control
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

To systematically summarize the cutting-edge achievements and technological breakthroughs in the field of pharmaceutical crystallization, and to establish a communication platform bridging academia and industry, this journal specially organizes a Special Issue themed "Research Progress in Pharmaceutical Crystallization". This Special Issue collects high-quality innovative research in the field, aiming to promote the development of both the discipline and related industries. Pharmaceutical crystallization is a core unit operation in the preparation of active pharmaceutical ingredients (APIs). Its crystal structure and polymorphic properties directly regulate the solubility, stability, and bioavailability of drugs, and are closely associated with the performance of pharmaceutical formulations. Crystal quality directly affects the efficacy and safety of formulations, serving as a key link in drug research and development as well as quality control. Targeting researchers worldwide, this Special Issue covers basic research and industrial transformation achievements, including core directions such as pharmaceutical polymorph screening, pharmaceutical crystal morphology regulation, and pharmaceutical formulations, with a focus on crystallization technologies and their integrated applications in formulations. Guest-edited by renowned experts in the field, the Special Issue accepts research papers, reviews, and other types of manuscripts, so as to facilitate technological iteration and the integration of industry, university, and research.

Dr. Shuai Yu
Dr. Shichao Du
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Crystals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2100 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pharmaceutical crystallization
  • pharmaceutical polymorphism
  • morphology regulation
  • particle size control
  • physical pharmaceutics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop